Dermatomyositis after interferon alpha treatment-Reference-Cited by-同舟云学术

Dermatomyositis after interferon alpha treatment

Published:2000-02 Issue:1 Volume:17 Page:64-69
ISSN:1357-0560
Container-title:Medical Oncology
language:en
Short-container-title:Med Oncol

Author:

Dietrich LL,Bridges AJ,Albertini MR

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,Hematology,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/BF02826219.pdf

Reference59 articles.

1. Dalakas M. Polymyositis, Dermatomyositis and inclusion body motositis.New Engl J Med 1991;325: 1487–1498.

2. Banker BQ, Engel AG. The polymyositis and dermatomyositis syndromes. In: Engel AG, Banker BQ (eds).Myology. New York: McGraw-Hill, 1986, pp 1385–1422.

3. Carpenter S. Resin histology and electron microscopy in inflammatory myopathy. In: Dalakas MC (ed).Polymyositis and Dermatomyositis Boston: Butterworths, 1988, 195–215.

4. Arahata K, Engel AG. Monoclonal antibody analysis of mononuclear cells in myopathies. I: Quantitation of subsets according to diagnosis and sites of accumulation and demonstration and counts of muscle fibers invaded by T cells.Ann. Neurol 1984;16: 193–208.

5. Engel AG, Arahata K. Mononuclear cells in myopathies: quantitation of functionally distinct subsets, recognition of antigen-specific cell-mediated cytotoxicity in some diseases and implications for the pathogenesis of the different inflammatory myopathies.Hum Pathol 1986;17: 704–721.

Cited by 62 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Causes and Clinical Presentation of Drug-Induced Dermatomyositis;JAMA Dermatology;2024-02-01

2. Environmental exposures as risk factors for idiopathic inflammatory myopathies;Journal of Autoimmunity;2023-11

3. IFN-α: A key therapeutic target for multiple autoimmune rheumatic diseases;Drug Discovery Today;2021-10

4. Cutaneous Adverse Reactions to COVID-19 Vaccines: Insights from an Immuno-Dermatological Perspective;Vaccines;2021-08-25

5. Systemic lupus erythematosus overlapping dermatomyositis owing to a heterozygous TREX1 Asp130Asn missense mutation;Clinical Immunology;2021-06